Florian Vogl

Plus aucun poste en cours

Health Technology

Consumer Services

Profil

Dr. Florian D.
Vogl was previously employed as a Chief Medical Officer by Immutep Ltd., a Chief Medical Officer by Cellestia Biotech AG, and a Head-Clinical Development Europe by Rainier Therapeutics, Inc. He received his doctorate degree from Ludwig-Maximilians-Universität München.

Anciens postes connus de Florian Vogl

Sociétés	Poste	Fin
Cellestia Biotech AG Cellestia Biotech AG Pharmaceuticals: MajorHealth Technology Manufactures anti-cancer drugs	Directeur Technique/Scientifique/R&D	01/05/2023
Rainier Therapeutics, Inc. Rainier Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company developing a targeted biologic for the potential treatment of both early stage and metastatic bladder cancer	Corporate Officer/Principal	01/12/2019
IMMUTEP LIMITED	Directeur Technique/Scientifique/R&D	-

Voir l'expérience en détail de Florian Vogl

Formation de Florian Vogl

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Florian Vogl

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	4
Immutep Ltd. Immutep Ltd. BiotechnologyHealth Technology Engages in the development of anti-cancer therapeutics	Health Technology
Ludwig-Maximilians-Universität München Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Rainier Therapeutics, Inc. Rainier Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company developing a targeted biologic for the potential treatment of both early stage and metastatic bladder cancer	Health Technology
Cellestia Biotech AG Cellestia Biotech AG Pharmaceuticals: MajorHealth Technology Manufactures anti-cancer drugs	Health Technology